Alfacell's ONCONASE, Radiation Sensitizer for Lung Cancer Treatment

Oct. 30 , 2007 -... "ONCONASE significantly reduced the tumor hypertension that is the major physiological barrier of therapeutic delivery to solid tumors," said Dr. Lee. "As a result, ONCONASE increased tumor penetration and selectively increased tumor blood flow. This investigation suggests that ONCONASE may be a new and promising drug in the treatment of non-small cell lung carcinoma patients as a radiation therapy enhancer."... Alfacell's Press Release -